Connect with us on LinkedIn Follow us on Twitter Find us on Facebook

King of Prussia-based CSL Behring Provides Update on COVID-19 Vaccine, Therapy Efforts

Published Wednesday, October 28, 2020 9:00 am

The biopharmaceutical company got an early start in the fight against the deadly virus because it received early reports from its manufacturing plant in Wuhan, China. The company responded quickly, beginning work on a vaccine and looking at other internal products that could potentially help those already infected. Click here to read the entire article.